Kishan and colleagues found that men with PSA levels of 0.51-1.00 ng/mL had a reduction in mortality risk with the addition of hormone therapy (HR 0.72, 95% CI 0.54-0.96), as did those with PSA levels ...
A new study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to postoperative radiotherapy may provide little survival benefit for most men ...
While many people are familiar with mammograms and smear tests, prostate screening is talked about far less.To shed light on this important subject ahead of Prostate Cancer Awareness Month in March, ...
PSA's February 2026 Price Hike Details PSA implemented these psa grading price increases in February 2026 to match surging ...
Retail prices of regular milled rice increased in early February, while farmgate prices of palay also posted gains at the start of the year, data from the ...
A newer type of prostate cancer scan called 64 Cu-SAR-bisPSMA found more than twice as many cancer spots as a commonly used PSMA PET scan in men whose prostate-specific antigen (PSA) was rising after ...
A single PSA test at midlife may identify men with a low risk of prostate cancer for up to 20 years, supporting longer screening intervals. Men with a low baseline PSA level at midlife have a low risk ...
Psoriasis was associated with significantly lower circulating brain-derived neurotrophic factor levels compared with healthy control individuals. Patients with psoriasis may have lower circulating ...
SANTIAGO, Feb 10 (Reuters) - Output at Codelco's El Teniente mine, the site of a deadly accident last year that has hit production, will be depressed for about the next five years, mine head Claudio ...
A negative PSMA-PET/CT at BCR identified a favorable-risk group with 2- and 5-year PFS of 78.3% and 62.4%, respectively, despite no visible lesions. Whole-pelvis radiotherapy improved PFS in locally ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results